These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10958921)

  • 1. Immune response to influenza vaccine in healthy elderly: lack of association with plasma beta-carotene, retinol, alpha-tocopherol, or zinc.
    Gardner EM; Bernstein ED; Popoff KA; Abrutyn E; Gross P; Murasko DM
    Mech Ageing Dev; 2000 Aug; 117(1-3):29-45. PubMed ID: 10958921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study.
    Sundaram ME; Meydani SN; Vandermause M; Shay DK; Coleman LA
    Nutr Res; 2014 Feb; 34(2):149-54. PubMed ID: 24461316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The age-associated decline in immune function of healthy individuals is not related to changes in plasma concentrations of beta-carotene, retinol, alpha-tocopherol or zinc.
    Gardner EM; Bernstein ED; Dorfman M; Abrutyn E; Murasko DM
    Mech Ageing Dev; 1997 Mar; 94(1-3):55-69. PubMed ID: 9147360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine production after influenza vaccination in a healthy elderly population.
    Bernstein ED; Gardner EM; Abrutyn E; Gross P; Murasko DM
    Vaccine; 1998 Nov; 16(18):1722-31. PubMed ID: 9778748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly.
    Murasko DM; Bernstein ED; Gardner EM; Gross P; Munk G; Dran S; Abrutyn E
    Exp Gerontol; 2002; 37(2-3):427-39. PubMed ID: 11772530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children.
    Bernstein DI; Yan L; Treanor J; Mendelman PM; Belshe R;
    Pediatr Infect Dis J; 2003 Jan; 22(1):28-34. PubMed ID: 12544405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects.
    Fülöp T; Wagner JR; Khalil A; Weber J; Trottier L; Payette H
    J Gerontol A Biol Sci Med Sci; 1999 Feb; 54(2):M59-64. PubMed ID: 10051856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients.
    Van Hoecke C; Prikazsky V; Utö I; Menschikowski C
    Gerontology; 1996; 42(4):190-8. PubMed ID: 8832266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing.
    McElhaney JE; Meneilly GS; Lechelt KE; Beattie BL; Bleackley RC
    Vaccine; 1993; 11(10):1055-60. PubMed ID: 8212827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.
    Matsumoto H; Ohfuji S; Watanabe K; Yamagami H; Fukushima W; Maeda K; Kamata N; Sogawa M; Shiba M; Tanigawa T; Tominaga K; Watanabe T; Fujiwara Y; Hirota Y; Arakawa T
    J Gastroenterol; 2015 Aug; 50(8):876-86. PubMed ID: 25672513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine.
    Powers DC; Belshe RB
    J Infect Dis; 1993 Mar; 167(3):584-92. PubMed ID: 8440930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
    Vogtländer NP; Brown A; Valentijn RM; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2004 Jun; 22(17-18):2199-201. PubMed ID: 15149777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for poor immune response to influenza vaccination in elderly people.
    Bellei NC; Carraro E; Castelo A; Granato CF
    Braz J Infect Dis; 2006 Aug; 10(4):269-73. PubMed ID: 17293910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma alpha-tocopherol, beta-carotene, and retinol levels in the institutionalized elderly individuals and in young adults.
    Morinobu T; Tamai H; Tanabe T; Murata T; Manago M; Mino M; Hirahara F
    Int J Vitam Nutr Res; 1994; 64(2):104-8. PubMed ID: 7960487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cellular immune response to influenza virus vaccination in aged humans.
    Fagiolo U; Amadori A; Cozzi E; Bendo R; Lama M; Douglas A; Palù G
    Aging (Milano); 1993 Dec; 5(6):451-8. PubMed ID: 8161577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population.
    Gardner EM; Bernstein ED; Dran S; Munk G; Gross P; Abrutyn E; Murasko DM
    Vaccine; 2001 Sep; 19(32):4610-7. PubMed ID: 11535308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of inactivated influenza virus vaccine in young children in 2003-2004.
    Mitchell DK; Ruben FL; Gravenstein S
    Pediatr Infect Dis J; 2005 Oct; 24(10):925-7. PubMed ID: 16220095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.